Zobrazeno 1 - 10
of 637
pro vyhledávání: '"low-dose naltrexone"'
Publikováno v:
Journal of Pain Research, Vol Volume 17, Pp 1273-1284 (2024)
Norman J Marcus,1,2 Lexi Robbins,1 Aya Araki,1 Edward J Gracely,3,4 Theoharis C Theoharides5,6 1Norman Marcus Pain Institute, New York, NY, USA; 2Department of Anesthesiology and Neurological Surgery, Weill Cornell Medicine, New York, NY, USA; 3Famil
Externí odkaz:
https://doaj.org/article/7a87d43a0abe462a9b018486418e8f1f
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Long COVID is a condition that develops in a subset of patients after COVID-19 infection comprising of symptoms of varying severity encompassing multiple organ systems. Currently, long COVID is without consensus on a formal definition, identifiable b
Externí odkaz:
https://doaj.org/article/a00811c1ea604e5293d554873a9738b5
Autor:
Anar Isman, Andy Nyquist, Bailey Strecker, Girish Harinath, Virginia Lee, Xingyu Zhang, Sajad Zalzala
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 36, Iss , Pp 100733- (2024)
A subset of patients experiences persistent fatigue symptoms after COVID-19, and patients may develop long COVID, which is characterized by lasting systemic symptoms. No treatments for this condition have been validated and are urgently warranted. In
Externí odkaz:
https://doaj.org/article/abd13f6ee00f4f2ab54df43452fa7226
Publikováno v:
Journal of Pain Research, Vol Volume 16, Pp 1993-1998 (2023)
Anne Marie McKenzie-Brown,1 David W Boorman,1 Kristen R Ibanez,2 Ezihe Agwu,3 Vinita Singh1 1Department of Anesthesiology, School of Medicine, Emory University, Atlanta, GA, USA; 2School of Medicine, University of Central Florida, Orlando, FL, USA; 3
Externí odkaz:
https://doaj.org/article/eba7a5c10cbd4dfabc111f1c8a443bda
Publikováno v:
Journal of Pain Research, Vol Volume 16, Pp 1017-1023 (2023)
Juan Yang,1 Kyung-Min Shin,2 Alex Do,1 Dennis M Bierle,1 Abd Moain Abu Dabrh,3 Ziying Yin,4 Brent A Bauer,1 Arya B Mohabbat1 1Division of General Internal Medicine, Mayo Clinic, Rochester, MN, 55905, USA; 2KM Science Research Division, Korea Institut
Externí odkaz:
https://doaj.org/article/e2c366c41ee4466696d60647e9c0c03b
Publikováno v:
Cancers, Vol 16, Iss 6, p 1240 (2024)
Naltrexone (NTX) is a non-selective antagonist of opioid receptors, primarily used in the therapy of opioid and alcohol dependence. Low-dose naltrexone (LDN) exhibits antagonistic action against the opioid growth factor receptor (OGFr), whose signali
Externí odkaz:
https://doaj.org/article/e46c1b3558654c95b55d8d4776045195
Autor:
Sarah Partridge, Lisa Quadt, Monica Bolton, Jessica Eccles, Charlie Thompson, Alessandro Colasanti, Stephen Bremner, Christopher Iain Jones, Karin Due Bruun, Harm Van Marwijk
Publikováno v:
Heliyon, Vol 9, Iss 5, Pp e15638- (2023)
Background: Low dose naltrexone (LDN) is used off-label by many individuals with fibromyalgia to help manage their pain. There is no current systematic literature review summarising the evidence to support this use of LDN. The objectives of this stud
Externí odkaz:
https://doaj.org/article/f235d8f700b94f5aaf8df3a899a0e66d
Autor:
Karin Due Bruun, Kirstine Amris, Henrik Bjarke Vaegter, Morten Rune Blichfeldt-Eckhardt, Anders Holsgaard-Larsen, Robin Christensen, Palle Toft
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-13 (2021)
Abstract Background Low-dose naltrexone (LDN) is used widely as an off-label treatment for pain despite limited evidence for its effectiveness. A few small trials with a high risk of bias have investigated the effect of LDN on pain associated with fi
Externí odkaz:
https://doaj.org/article/e11833aca1794dada6f0faafbdd3d3eb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.